Abstract: The present disclosure relates to a method and apparatus for representing dynamic neural radiance fields from unsynchronized videos. A method of acquiring a video at an arbitrary viewpoint based on a dynamic neural radiance fields model according to an embodiment of the present disclosure may comprise: inputting one or more videos acquired from one or more views for one scene into the dynamic neural radiance fields model; inputting a time embedding for the one or more videos into the dynamic neural radiance fields model; and rendering the video at the arbitrary viewpoint based on color information and density information output by the dynamic neural radiance fields model. Herein, time synchronization related to the time embedding may be performed by applying an individual time offset learned for each view, for the one or more views.

Abstract: This application relates to isolated antibodies, or antigen-binding fragments thereof, that bind to at least one isoform of cluster of differentiation 97 (CD97), also known as adhesion G protein-coupled receptor E5 (ADGRE5), antibody-drug conjugates comprising such antibodies or antigen-binding fragments, as well as polynucleotides and vectors that encode for such antibodies or antigen-binding fragments. This application further relates to methods of producing the antibodies or antigen-binding fragments and using the antibodies or antigen-binding fragments for treatment of diseases.

Abstract: A method and reactor for a hybrid thermo-electrochemical cycle using a layered reactive element is disclosed. The method includes heating the reactive element with a heat source, the reactive element having a metal oxide core that is redox-active, an outer layer, and an ion conductor layer between the core and the outer layer. The method includes increasing a chemical potential of oxygen in the core, driving O2? ions out as O2, the chemical potential increased through applying a first bias voltage between the core and the outer layer. The method includes exposing the reactive element to an input gas, and decreasing the chemical potential of oxygen in the core, driving oxygen from the input gas into the core leaving a gas product, the chemical potential decreased through applying a second bias voltage between the core and the outer layer. The first and second bias voltages have opposite polarity.

Abstract: A method includes forming a first pull-up transistor and a first pass-gate transistor over a substrate at a first level height, the first pull-up and first pass-gate transistors being of a dual port static random access memory (SRAM) cell; forming a first pull-down transistor and a second pass-gate transistor of the dual port SRAM cell over the substrate at a second level height; forming a second pull-down transistor and a third pass-gate transistor of the dual port SRAM cell over the substrate at a third level height; forming a second pull-up transistor and a fourth pass-gate transistor of the dual port SRAM cell over the substrate at a fourth level height.

Abstract: Systems and methods for generating and manipulating a guided electromagnetic wave in a waveguide are provided. The optical system includes a waveguide, such as a two-dimensional waveguide, and an optical element disposed adjacent the surface of the waveguide. To generate the guided electromagnetic wave, a converging laser beam is generated and coupled to the waveguide by steering the converging laser beam towards an edge of the waveguide and with a beam center trajectory approximately parallel to a surface of the waveguide.

Abstract: An automatic generation method for three-dimensional morphology of ruts in asphalt pavements comprises: constructing a standard rut cross-section representation model, classifying ruts, acquiring detection data of a rutted section of an asphalt pavement, selecting different rut cross-sections at equal intervals in a longitudinal direction of the pavement, denoising and smoothening the rut cross-sections, selecting feature points according to geometric fluctuation features of the rut cross-sections, connecting the feature points and fitting a cross-sectional curve based on an evolution law of rut deformation, and fusing multiple reconstructed rut cross-sections to realize automatic generation and visualization of three-dimensional morphology of a rut.

Abstract: This disclosure provides methods that render hydrophobic carbon fiber paper (CFP) hydrophilic for extended periods without damaging the carbon fibers that compose the CFP or the architecture of the network of those carbon fibers. The disclosure further provides hydrophilic CFP made by the inventive methods. The methods include sonicating the CFP in an aqueous surfactant solution followed by electrooxidizing the CFP in an aqueous electrolyte.

Abstract: Carbonized cellulose fiber electrodes for high-frequency electrochemical capacitors and method for fabricating the same is disclosed. The method includes carbonizing a cellulose fiber substrate by subjecting the cellulose fiber substrate to a rapid pyrolysis process in a preheated furnace having an inert environment at a pyrolysis temperature of at least 1000° C., resulting in a carbonized cellulose substrate. The method also includes preparing a hydrothermal solution, and depositing vertically oriented nanoflakes on the carbonized cellulose substrate by immersing the carbonized cellulose substrate in the hydrothermal solution and conducting a hydrothermal reaction, thereby forming the electrode. The vertically oriented nanoflakes may be composed of MoS2. The cellulose fiber substrate may be a cellulose tissue sheet.

Abstract: It is an object of the present invention to provide a preventive agent, a therapeutic agent or a therapeutic composition for steatohepatitis developed by phospholipid deficiency or decreased phospholipid synthesis in the liver, and to provide a therapeutic method for the aforementioned disease. More specifically, the present invention relates to a therapeutic agent for steatohepatitis, comprising, as an active ingredient, choline or a choline metabolite, ethanolamine or an ethanolamine metabolite, a salt thereof, or a solvate thereof, wherein the therapeutic agent for steatohepatitis is characterized in that the steatohepatitis is developed by decreased phospholipid synthesis in the liver. Examples of the choline metabolite may include betaine, dimethylglycine, and phosphatidylcholine.

Abstract: This disclosure relates to delivery of various agents to the inner ear of a subject.

Abstract: Methods and compositions wherein crystalline woven and interlocked covalent organic frameworks (COFs) are used as additives to achieve combinations of high toughness and elasticity in polymers.

Abstract: The present disclosure relates to a multi-mode sensor based on wafer-level packaging and its manufacturing method. The sensor comprises a base for 3D packaging, a multi-mode sensor body, a cap layer, and multiple packaging structures. The base consists of a first substrate, a dielectric layer, a first insulating layer, and multiple through silicon vias (TSVs). The cap layer comprises a second substrate and a bonding ring, where the first surface of the second substrate is provided with a cavity for housing at least part of the multi-mode sensor body. This disclosure has the advantages of high integration, high performance, low cost, miniaturization, high reliability, process feasibility and compatibility, as well as high wafer-level uniformity, making it suitable for a wide range of applications.

Abstract: Method for nanoparticle-mediated deposition of radiation (NMDR) and targeted radiation therapies using a biodegradable and bioabsorbable iron oxide nanoparticle with a biocompatible coating that is effective to overcome various extra- and intra-cellular barriers and selectively accumulate in solid and metastatic tumors to improve the energy transfer of conventional radiotherapy

Abstract: This disclosure relates to red mud compositions. This disclosure also relates to methods of making red mud compositions. This disclosure additionally relates to methods of using red mud compositions.

Abstract: A method for assessing acute kidney injury of inpatient includes the following steps. An electronic medical record data of an inpatient is captured by a processor, and the electronic medical record data includes a baseline basic serum creatinine concentration data. A target serum creatinine concentration data and a minimum post-admission serum creatinine concentration data of the inpatient are captured by the processor. A dynamic-increasing value of serum creatinine concentration is calculated to obtain by the processor based on the target serum creatinine concentration data, the baseline basic serum creatinine concentration data and the minimum post-admission serum creatinine concentration data. The dynamic-increasing value of serum creatinine concentration is analyzed by the processor to assess whether the inpatient is an inpatient suffering the acute kidney injury or not.

Abstract: A cement composition includes an ordinary Portland cement, an Arabic Gum in the amount of 0.1 to 2% by weight of the ordinary Portland cement, a sand in the amount of 150% by weight of the ordinary Portland cement, and water in the amount of 40% by weight of the ordinary Portland cement. A cured sample obtained by curing the cementitious mortar composition for at least 2 days has a porous structure including one or more microcracks from 20 to 500 nm wide and 0.1 to 500 ?m long, wherein the cured sample has granules from 1 to 20 ?m in diameter, the granules are bundles of microfilaments with a length from 0.2 to 5 ?m, the bundles have 20 to 1000 microfilaments, and the microfilaments are in the form of cylinders.

Abstract: Provided herein is a recombinant AAV (rAAV) comprising an AAV capsid and a vector genome packaged therein, wherein the vector genome comprises an AAV 5? inverted terminal repeat (ITR), an expression cassette comprising an open reading frame (ORF) for a mature human Lamin A (hLaminA) under control of a regulatory sequence which direct expression of mature hLaminA in a target cell, and an AAV 3? ITR. Also provided is a pharmaceutical composition comprising a rAAV as described herein in a formulation buffer, and a method of treatment of idiopathic dilated cardiomyopathy (DCM) or a disease associated with a mutation in a Lamin A (LMNA) gene.

Abstract: A bone conduction hearing-aid unit embedded under a scalp. The bone conduction hearing-aid unit includes a vibration generator configured to generate vibration, and an anchor. A magnetic field frequency is applied to the vibration generator from the outside of the scalp to generate vibration. The vibration is transmitted to a skull via the anchor.

Abstract: Systems and methods for fabricating a highly power efficient p-i-n diode-based THz radiating array in accordance with embodiments of the invention are illustrated. One embodiment includes a p-i-n diode-based intercoupled THz radiating array, including: a plurality of radiating array elements, wherein each array element comprises an oscillator core oscillating at a fundamental frequency, and where the oscillator core of each array element is locked to an adjacent oscillator core through a coupling network comprising T-lines; and a p-i-n diode coupled to the oscillator core of each array element and configured to produce harmonics of the fundamental frequency from a signal from the oscillator core.

Abstract: The present invention relates to the field of cancer. More specifically, the present invention provides methods and compositions useful for detecting and treating prostate cancer. In a specific embodiment, a method for identifying a patient as having aggressive prostate cancer comprising the step of detecting overexpression relative to a control of epithelial cell adhesion molecule (EpCAM), H4 clustered histone 5 (H4C5), and tetratricopeptide repeat domain 3 (TTC3) in a urine sample obtained from the patient. In a more specific embodiment, the detecting step comprises detecting protein or ribonucleic acid (RNA) level of EPCAM, H4C5 and TTC3. In another specific embodiment, the method further comprises detecting overexpression relative to a control of one or more of messenger ribonucleic acid (mRNA), circulating RNA (circRNA), extracellular DNA and long non-coding RNA (lncRNA). The method can further comprise detecting metabolites.